Contrast

Contact

Share

Donate

MyChart

Help

Yale New Haven Hospital construction to bring more than $1 billion of positive economic impact to the state of Connecticut

Monday, October 7, 2019

New Haven, CT (Oct. 7, 2019) – Yale New Haven Hospital today announced the results of a study demonstrating the significant positive economic impact that its new state-of-the-art Neuroscience Center will have in the region. According to the CT Economic Resource Center (CERC), construction of the new Neuroscience Center on YNHH’s Saint Raphael Campus, announced in April, is estimated to generate more than a $1 billion impact in the state.

“The new Neuroscience Center is clearly going to be a win-win situation,” said Marna P. Borgstrom, CEO Yale New Haven Hospital/Yale New Haven Health. “Not only will patients in our region have access to the most advanced neurological care, but the state and its residents will benefit economically from the project and its associated impact.”

The $838 million project, which is expected to open in 2024, will include two new patient facilities on the Saint Raphael campus that will focus on innovative collaboration between Yale School of Medicine and Yale New Haven Hospital. The new 505,000 square-foot project will have 204 inpatient beds for patients seeking innovative care from movement disorders to neuro-regeneration. The project also includes a significant expansion of the Emergency Department on the SRC Campus.

“Partnering with Yale New Haven Hospital on this exciting project is a no-brainer for Connecticut,” said Governor Ned Lamont. “This state of the art facility is yet another example that YNHH and New Haven are leaders in medicine and research. I know the Neuroscience Center on the Saint Raphael Campus will yield incredible results not only for future patients, but for the greater New Haven community and for the state as a whole.”

The economic activity from the construction, demolition and renovation projects associated with the Neuroscience Project will support over 6,400 jobs in the state as the increase in production across the state and household spending ripples through Connecticut’s economy. Other industries will also be impacted thanks to the new jobs: retail trade, rental, restaurants and entertainment, technical and household services and more.

“The investment this project represents: long-term prosperity, long-term relationships, jobs, stability and yes, dollars and cents; sends the strong signal that Yale New Haven Health and the City of New Haven will continue walking side by side long into the future,” Mayor Toni N. Harp said. “This proposed Neurology Center will underscore Yale New Haven Health’s position as a global leader in 21st century healthcare services – and cement New Haven’s place as the home and destination for these services.”

The Neuroscience Center will be built within the existing footprint of the hospital campus, bordered by Sherman Avenue and George Street. It will shift the main entrance of the hospital from Chapel Street to George Street. An existing parking garage on Orchard Street will be extended to George Street to accommodate patients and a new 200-space underground garage will support the facility.

Yale New Haven Hospital (YNHH), part of Yale New Haven Health, is a nationally recognized, 1,541-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale School of Medicine (YSM). Founded as the fourth voluntary hospital in the U.S. in 1826, today, YNHH has two New Haven-based campuses, and also includes Yale New Haven Children's Hospital, Yale New Haven Psychiatric Hospital and Smilow Cancer Hospital. YNHH has received Magnet designation from the American Nurses Credentialing Center, the nation’s highest honor of nursing excellence. YNHH has a combined medical staff of about 4,500 university and community physicians practicing in more than 100 specialties. www.ynhh.org

Similar Articles

9/24/2021

Yale New Haven Health announces it is now administering COVID-19 dose 3 and boosters

New Haven, CT (Sept. 24, 2021) – Yale New Haven Health System (YNHHS) today announced that it has begun offering booster and dose three vaccinations at select sites across the state.

9/15/2021

Marna Borgstrom to retire in 2022 as CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – After more than 43 years of exceptional service, Marna P. Borgstom has announced her intent to retire as chief executive officer of Yale New Haven Health. Her retirement is effective on March 25 2022.

9/15/2021

Christopher O’Connor to become CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – Christopher O’Connor has been named the CEO of Yale New Haven Health (YNHHS), effective March 25, 2022 when current CEO Marna P. Borgstrom retires, announced Vince Calarco, Chair of the YNHHS Board of Trustees. O’Connor currently serves as president of the Health System having been named to that position in August of 2020.